{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2023,9,29]],"date-time":"2023-09-29T14:12:55Z","timestamp":1695996775324},"reference-count":7,"publisher":"Springer Science and Business Media LLC","issue":"8","license":[{"start":{"date-parts":[[2010,3,27]],"date-time":"2010-03-27T00:00:00Z","timestamp":1269648000000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["J Neurol"],"published-print":{"date-parts":[[2010,8]]},"DOI":"10.1007\/s00415-010-5521-8","type":"journal-article","created":{"date-parts":[[2010,3,26]],"date-time":"2010-03-26T04:08:58Z","timestamp":1269576538000},"page":"1404-1405","source":"Crossref","is-referenced-by-count":7,"title":["Guillain-Barr\u00e9 syndrome after short-course efalizumab treatment"],"prefix":"10.1007","volume":"257","author":[{"given":"Marco","family":"Turatti","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Stefano","family":"Tamburin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Domenico","family":"Idone","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Maria Luigia","family":"Praitano","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Giampietro","family":"Zanette","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2010,3,27]]},"reference":[{"key":"5521_CR1","doi-asserted-by":"crossref","first-page":"896","DOI":"10.1111\/j.1365-2133.2009.09059.x","volume":"160","author":"M Caproni","year":"2009","unstructured":"Caproni M, Volpi W, Chiarini C, Antiga E, Giomi B, Fabbri P (2009) A case of natural killer cell monoclonal expansion during efalizumab treatment in a patient with psoriasis. Br J Dermatol 160:896\u2013897","journal-title":"Br J Dermatol"},{"key":"5521_CR2","first-page":"2085","volume":"3101","author":"BM Kuehn","year":"2009","unstructured":"Kuehn BM (2009) Efalizumab withdrawn. JAMA 3101:2085","journal-title":"JAMA"},{"key":"5521_CR3","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1002\/1529-0131(200002)43:2<243::AID-ANR2>3.0.CO;2-K","volume":"43","author":"FW Miller","year":"2000","unstructured":"Miller FW, Hess EV, Clauw DJ, Hertzman PA, Pincus T, Silver RM, Mayes MD, Varga J, Medsger TA, Love LA (2000) Approaches for identifying and defining environmentally associated rheumatic disorders. Arthritis Rheum 43:243\u2013249","journal-title":"Arthritis Rheum"},{"key":"5521_CR4","doi-asserted-by":"crossref","first-page":"476","DOI":"10.1212\/WNL.58.3.476","volume":"58","author":"R Press","year":"2002","unstructured":"Press R, Ozenci V, Kouwenhoven M, Link H (2002) Non-T (H) 1 cytokines are augmented systematically early in Guillain-Barr\u00e9 syndrome. Neurology 58:476\u2013478","journal-title":"Neurology"},{"key":"5521_CR5","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1002\/mus.20924","volume":"37","author":"JP Stubgen","year":"2008","unstructured":"Stubgen JP (2008) Tumor necrosis factor-alpha antagonists and neuropathy. Muscle Nerve 37:281\u2013292","journal-title":"Muscle Nerve"},{"key":"5521_CR6","doi-asserted-by":"crossref","first-page":"939","DOI":"10.1016\/S1474-4422(08)70215-1","volume":"7","author":"PA Doorn van","year":"2008","unstructured":"van Doorn PA, Ruts L, Jacobs BC (2008) Clinical features, pathogenesis, and treatment of Guillain-Barr\u00e9 syndrome. Lancet Neurol 7:939\u2013950","journal-title":"Lancet Neurol"},{"key":"5521_CR7","doi-asserted-by":"crossref","first-page":"1396","DOI":"10.1001\/archderm.144.10.1396","volume":"144","author":"F Victor","year":"2008","unstructured":"Victor F, Menon K, Latkowski JA, Fernandez-Obregon A, Strober BE (2008) Efalizumab-associated Guillain-Barre syndrome. Arch Dermatol 144:1396\u20131397","journal-title":"Arch Dermatol"}],"container-title":["Journal of Neurology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00415-010-5521-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00415-010-5521-8\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00415-010-5521-8","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,5,28]],"date-time":"2019-05-28T15:12:57Z","timestamp":1559056377000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00415-010-5521-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2010,3,27]]},"references-count":7,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2010,8]]}},"alternative-id":["5521"],"URL":"https:\/\/doi.org\/10.1007\/s00415-010-5521-8","relation":{},"ISSN":["0340-5354","1432-1459"],"issn-type":[{"value":"0340-5354","type":"print"},{"value":"1432-1459","type":"electronic"}],"subject":[],"published":{"date-parts":[[2010,3,27]]}}}